β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathwayTao Tian, Yujuan Yang, Xiao Fu et al.|Journal of International Medical Research|2018Cited by 18
Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroidsKejun Nan|OncoTargets and Therapy|2014Cited by 13